SVC Q1 2026 Earnings Substantial EPS Miss Amid Operational Headwinds TGLS Q1 2026 Earnings EPS Beat Amid Cautious Market Sentiment Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Advances ANRO Q1 2026 Earnings Significant EPS Miss Highlights EarlyStage Development Costs CMTL Q1 2026 Earnings EPS Surprise Beats Estimates by 41 Stock Advances USPH Q1 2026 Earnings EPS Misses Estimates by 1725 but Stock Gains 332